Hamstra DA - Search Results

1

Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature.

Murphy JD, Spalding AC, Somnay YR, Markwart S, Ray ME, Hamstra DA. Murphy JD, et al. Among authors: hamstra da. Clin Cancer Res. 2009 Jan 15;15(2):589-96. doi: 10.1158/1078-0432.CCR-08-1019. Clin Cancer Res. 2009. PMID: 19147764

2

Expression of endogenously activated secreted or cell surface carboxypeptidase A sensitizes tumor cells to methotrexate-alpha-peptide prodrugs.

Hamstra DA, Pagé M, Maybaum J, Rehemtulla A. Hamstra DA, et al. Cancer Res. 2000 Feb 1;60(3):657-65. Cancer Res. 2000. PMID: 10676650

3

Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker.

Hall DE, Moffat BA, Stojanovska J, Johnson TD, Li Z, Hamstra DA, Rehemtulla A, Chenevert TL, Carter J, Pietronigro D, Ross BD. Hall DE, et al. Among authors: hamstra da. Clin Cancer Res. 2004 Dec 1;10(23):7852-9. doi: 10.1158/1078-0432.CCR-04-1218. Clin Cancer Res. 2004. PMID: 15585617

4

Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D.

Moffat BA, Chen M, Kariaapper MS, Hamstra DA, Hall DE, Stojanovska J, Johnson TD, Blaivas M, Kumar M, Chenevert TL, Rehemtulla A, Ross BD. Moffat BA, et al. Among authors: hamstra da. Clin Cancer Res. 2006 Mar 1;12(5):1525-32. doi: 10.1158/1078-0432.CCR-05-1408. Clin Cancer Res. 2006. PMID: 16533777

5

Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy.

Lee KC, Hamstra DA, Bhojani MS, Khan AP, Ross BD, Rehemtulla A. Lee KC, et al. Among authors: hamstra da. Clin Cancer Res. 2007 Mar 15;13(6):1839-46. doi: 10.1158/1078-0432.CCR-06-1657. Clin Cancer Res. 2007. PMID: 17363540

6

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.

Hamstra DA, Rehemtulla A, Ross BD. Hamstra DA, et al. J Clin Oncol. 2007 Sep 10;25(26):4104-9. doi: 10.1200/JCO.2007.11.9610. J Clin Oncol. 2007. PMID: 17827460 Review.

7

Radiation therapy reduces local failure and improves overall survival in sPNET.

Spalding AC, Hamstra DA. Spalding AC, et al. Among authors: hamstra da. Pediatr Blood Cancer. 2008 Jul;51(1):148; author reply 149-50. doi: 10.1002/pbc.21513. Pediatr Blood Cancer. 2008. PMID: 18273871 Free article. No abstract available.

8

Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis.

Vuyyuri SB, Hamstra DA, Khanna D, Hamilton CA, Markwart SM, Campbell KC, Sunkara P, Ross BD, Rehemtulla A. Vuyyuri SB, et al. Among authors: hamstra da. Clin Cancer Res. 2008 Apr 1;14(7):2161-70. doi: 10.1158/1078-0432.CCR-07-1954. Clin Cancer Res. 2008. PMID: 18381958

9

Gemcitabine-mediated radiosensitization of human soft tissue sarcoma.

Murphy JD, Lucas DR, Somnay YR, Hamstra DA, Ray ME. Murphy JD, et al. Among authors: hamstra da. Transl Oncol. 2008 Mar;1(1):50-6. doi: 10.1593/tlo.07121. Transl Oncol. 2008. PMID: 18607508 Free PMC article.

10

Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer.

Hamstra DA, Eisbruch A, Naidu MU, Ramana GV, Sunkara P, Campbell KC, Ross BD, Rehemtulla A. Hamstra DA, et al. Clin Cancer Res. 2010 May 1;16(9):2666-76. doi: 10.1158/1078-0432.CCR-09-3318. Epub 2010 Apr 13. Clin Cancer Res. 2010. PMID: 20388849 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters